The narrow toxic/therapeutic ratio ot theophylline in the management of airways obstruction (therapeutic range 10-20 fJ-g/m\) and neonatal apnoea (therapeutic range 5-15 fJ-g/ml) requires a technique for assaying urgent and small batches of samples. Chromatographic, radioimmunoassay, and EMIT methods are not always practical solutions. The Ames TDA Fluorostat* technique, a substrate-linked f1uoro-immuno assay procedure, was therefore compared to an established high-performance liquid chromatographic (HPLC) method.
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Materials and methods

FLUOROSTAT METHOD
The assay, based on the work of Li et al,1 was performed as described by the manufacturer. Briefly, theophylline labelled with umbelliferyl-B-ngalactoside (non-fluorescent), is incubated with 50 fJ-1 clinical sample, a limiting amount of theophylline antibody, and [3-D-galactosidase to yield a fluorescent product from the labelled substrate. This fluorescence, proportional to the theophylline concentration of the sample, is measured in a dedicated fluorimeter whose microprocessor converts the results into concentration units (fJ-g/ml or umoljl) using a standard curve constructed from supplied calibrants. The working range without dilution was up to 40 fJ-g/m!. The preparation and cross-reactivity of this immunogen are described by Li Biochem, 1983; 20: 251-253 SAMPLES FOR METHOD COMPARISON Six blood samples were collected after the oral administration of 500 mg microcrystalline theophylline on 16 occasions from seven trialists, and 26 samples were collected from 24 adult and paediatric patients with airways obstruction and apnoea. These were separated and stored at -20°C before assay.
Ann C/in
ASSAY PRECISION MATERIALS
Between-and within-batch precision was determined at two levels using TheraChem control materials (A R Horwell Ltd, Kilburn High Road, London NU6 2BP, UK) and two trialist specimens, respectively.
STATISTICAL METHODS
The analysis of Cornbleet and Gochman'' was used using the computer program of Dr P Woods, Department of Chemical Pathology, Southampton General Hospital, Southampton S094XY, UK.
Results
ASSAY PRECISION F/uorostat method
The within-batch CYs (n= 14) on mean (±SD) values of 8·5±0·29 and 15·8±0·61 fJ-g/ml were 3-41 % and 3·87%, respectively. The between-batch CYs (n=20) on means of 8·3±0·56 and 28·0± 1·78 fJ-g/ml were 6·76% and 6·37%, respectively.
HPLC method
The within-batch CYs (n=20) on mean values of 8·1±0·19 and 14·8±0·34fJ-g/ml were 2·37% and 2· 32 %, respectively. The between-batch CYs (n=21) on means of 8·2±0·61 and 27·0±1·26 fJ-g/ml were 7 -45 % and 4· 68 %, respectively.
METHOD COMPARISON
The 96 trialist samples gave the following result: y=0·2867+1·0701x, r=0·9517, p<O·ool, standard error of regression = 15-4643, indicating that within the HPLC range 10·0-20·0 fJ-g/ml the TDA had a positive bias, giving a range of 11·0-21· 7 fJ-~/ m!. This was confirmed by cross comparison of the aqueous HPLC and serum TDA calibrants. The 26 patient samples gave similar results: y=0·4326+ 1·0276x, r=0·9702, p<O·OOl, standard error of regression = 4· 8957. 251
Discussion
The results showed that the precision of the methods was acceptable and a highly significant correlation existed between them. However, the TDA method has no cali brant between zero and 10·0 flog/ml, thus for trough results and apnoea prevention TDA precision would be improved by a 5 flog/ml cali brant, though the specificity of the immunogen is not stated for this concentration. Simple method programming, standard curve storage, and single point calibration made the Fluorostat easy to use and reduced the cost of single test assays. The dedicated fluorimeter, reagent shelf-life (12-15 months at 4°C), and simple technique ensured assay availability-an advantage over radioimmunoassay and chromatographic methods. The capital outlay for the HPLC and TDA systems are similar, and although the cost per test by TDA is higher, they compare favourably with EMIT3 and are offset by its faster response and shorter laboratory worker time to complete the assay. The TDA Fluorostat, also applicable to other drug assays, therefore provides a practicable solution for assaying theophylline in clinical laboratories.
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Effect of temperature on the stability of thyroid stimulating hormone in dried blood spots
E J COOMBES, T R GAMLEN, and G F BATSTONE Department of Chemical Pathology, Salisbury General Infirmary, Salisbury, Wilts SP2 7SX
Screening for neonatal hypothyroidism in the United Kingdom typically requires the collection of dried blood spots (DBS) onto filter paper cards and their dispatch to the screening laboratory for the thyrotrophin (TSH) assay. Available studies on the stability of DBS-TSH activity are inadequate Short reports because the numbers examined have been small or undisclosed and without statistical analysis.l f or the DBS-TSH activity was created artificially." We therefore investigated DBS-TSH stability at four temperatures over 30 days using samples collected during thyroliberin (TRH) testing.
Methods
SAMPLE COLLECTION
Venous blood was collected from 21 adult subjects 20 minutes after administration of intravenous TRH. The blood was collected into glass tubes with and without the presence of heparin anticoagulant. To confirm the relationship between DBS-TSH and serum TSH activity samples were similarly collected from a further 19 subjects undergoing routine thyroid function testing.
DBS FORMATION AND STORAGE
The heparinised sample was mixed, spotted onto cards (Reeves Angel Whatman No 160), air dried at room temperature, and stored at -20°C, 4°C, room temperature (range 19-26°C), and 37°C.
DBS-TSH ASSAY
Duplicate 6 mm DBS discs were punched from the card and assayed using the Abbott Laboratories Human Neonatal TSH Radioimmunoassay Diagnostic Kit, as described by the manufacturer. This is a three-day double antibody polyethylene glycol assisted procedure involving separate overnight incubation with antibody (at 37°C) and radiolabel (at room temperature).
Within-batch CYs of mean values 10·3, 30·1, and 118·7 mUll were 8·3% (n=6), 13·0~<; (n= 10), and 14·4% (n = 10), respectively, and between batch the same mean DBS values had CVs of 11·0% (n=27), 13.3% (n=28), and 13·0% (n=26), respectively.
SER UM TSH ASSAY
The Amerlex TSH radioimmunoassay (Kit 1M 2061) was used following the manufacturer's instructions (Amersham International pic).
Both serum and DBS-TSH assays were performed in disposable tubes (Starstedt 500 No 55 484 155 x 12 mm) with reagent addition by a sample processor (LKB 2071). Radioactivity was counted by an automatic gamma counter (LKB Wallac 1270 Rackgamma II) and results (mUll) were calculated using a spline function.
DBS-TSH STABILITY TESTING PROTOCOL DBS-TSH activity was assayed on the day of collection (day 0) and 1,3-4,6-8,9-10,20-22, and 26-30 days thereafter.
